You are scheduled for chemotherapy (Taxotere if you are being treated for prostate cancer) in a few days, so you stop eating until you complete the therapy session! This scenario could become typical in future treatment protocols. Published last week in Proceedings of the National Academy of Sciences was a study that found that starving [...]
Common practice is to treat men with advanced prostate cancer with androgen inhibition therapy (ADT) with or without antiandrogens (Casodex). Most of our prostate cancer will progress and develop into androgen-independent prostate cancer despite our achieving castrate testosterone levels. Dutasteride, a 5-alfa-reductase inhibitor, is commonly used in the treatment of benign prostatic hyperplasia (BPH). Additional, [...]
Highlights of the advance prostate cancer session meeting in Orlando, Florida included Abstract 531 which evaluated 6,437 men who had received androgen deprivation therapy for more than 1.5 years. According to the abstract Dementia and COPD were the main non-GU side effects associated with long-term androgen deprivation. Presented by Ziya Kirkall, MD, at the Annual [...]
When I returned from the conference (see yesterday’s post) I kept seeing notices and announcements from a new retrospective study out of John;s Hopkins that showed that men with prostate cancer tumors that recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two [...]
During radiation and chemotherapy, cancer patients including prostate cancer patients, should avoid the routine use of antioxidant supplements unless approved by their doctor. Supplements may reduce the anticancer benefits of therapy, researchers concluded in a commentary published online in the Journal of the National Cancer Institute. Radiation and Taxotere used for advanced prostate cancer therapy [...]